Wells Fargo (WFC)

CNBC’s final trades: INFL, Wells Fargo, Nutrien and Thermo Fisher. Wells Fargo beat Q2 estimates; Nutrien missed earnings but topped sales.

Gilead Sciences (NASDAQ:GILD) Chief Medical Officer Dietmar Berger outlined the company’s priorities across HIV, oncology and inflammation at the Wells Fargo conference, describing a portfolio that has expanded through internal development and acquisitions and is now entering a period of prioritizat

Here's why Oscar Health may be hardest hit from CVS' comments.

Johnson & Johnson (NYSE:JNJ) MedTech Chairman Tim Schmid said the company remains confident it is delivering growth at the high end of its previously stated 5% to 7% operational market-growth range for the 2022 through 2027 period, citing a portfolio shift toward cardiovascular products, operating-m

AbbVie (NYSE:ABBV) executives outlined growth plans across immunology, oncology and neuroscience at a Wells Fargo conference, emphasizing continued momentum for its SKYRIZI and RINVOQ franchises, a pipeline of combination therapies and an approach to business development focused on assets that fit i

Editas Medicine (NASDAQ:EDIT) is preparing to begin a first-in-human study of EDIT-401, an in vivo CRISPR-edited medicine designed to lower LDL cholesterol in patients with heterozygous familial hypercholesterolemia, Chief Executive Officer Gilmore O’Neill said during a Wells Fargo discussion. O’Ne

Medtronic (NYSE:MDT) executives said the medical device maker is seeing accelerating growth across major franchises and emerging product categories, supported by innovation in artificial intelligence, robotics and new therapies. Speaking at the Wells Fargo Healthcare Conference, Chairman and Chief

McKesson (NYSE:MCK) discussed its planned $2.25 billion acquisition of Precision Medicine Group, first-quarter operating trends and capital-allocation priorities during a presentation with Wells Fargo analyst Stephen Baxter. The company said Precision Medicine Group would expand two areas it has id

It ended its latest fiscal year quite impressively.

It wasn't because of the quarterly earnings report it published that month.

The much-anticipated launch led to a share price plunge.

Phreesia's Q2 EPS missed estimates, while sales beat. FY27 guidance held; shares fell 5.6%. Analysts kept bullish targets, Wells Fargo raised to $10.

In the past few months, investment banks have updated year end views on gold (“Au”) to US$4,500-$5,100/oz vs. the current price of ~$4,380. For example, Go

Digital identity verification and fraud prevention provider Socure has achieved a $5.2 billion valuation and buys following a strategic growth investment l

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...

Wall Street's hottest trend could prove costly for investors in two of the highest-flying AI stocks.

An analyst downgraded his recommendation on the reigning king of domain registrars.

The investment bank sees the massive housing shortage as a major opportunity.

What Happened? Shares of payment processing company Shift4 Payments (NYSE:FOUR) jumped 4.6% in the morning session after Wells Fargo upgraded the company to ...

Stephen Weiss picks Dick's Sporting Goods, supported by Wells Fargo's upgrade. Jim Lebenthal's final trade is BlackRock, recommended by Evercore ISI's analyst upgrade. Shannon Saccocia recommends iShares U.S. Industrials ETF and Joseph M. Terranova mentions Charles Schwab breaking up.

Dick's Sporting Goods saw sales rise 67% year over year in Q1.

It announced a $5 billion-plus deal to acquire a peer.

Since February 2026, Wells Fargo has been in a holding pattern, posting a small loss of 1.5% while floating around $83.87. The stock also fell short of the S...

What Happened? A number of stocks fell in the afternoon session after the White House pivoted its Iran strategy toward financial sanctions, signaling a de-es...

What Happened? Shares of general merchandise retailer Target (NYSE:TGT) jumped 4.5% in the morning session after second-quarter results beat on sales and the...